Human Fatty Acid Binding Protein (HFABP) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Human Fatty Acid Binding Protein (HFABP) antibodies (anti-Human Fatty Acid Binding Protein, anti-HFABP) and diagnostic hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP), OVA-Human Fatty Acid Binding Protein (HFABP), KLH-Human Fatty Acid Binding Protein (HFABP) antigens for Cardiovascular disease HFABP detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Cardiovascular disease diagnostics products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-HFABP-Ag01	BSA-Human Fatty Acid Binding Protein (HFABP)	$756.00
GMP-SMT-HFABP-Ag02	OVA-Human Fatty Acid Binding Protein (HFABP)	$756.00
GMP-SMT-HFABP-Ab01	Anti-human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)	$1953.00
GMP-SMT-HFABP-Ab02	Anti-human Fatty Acid Binding Protein (HFABP) human monoclonal antibody (mAb)	$1953.00

Size： 1mg | 10mg | 100mg

Product Description

BSA-Human Fatty Acid Binding Protein (HFABP)

Cat No.	GMP-SMT-HFABP-Ag01
Product Name	BSA-Human Fatty Acid Binding Protein (HFABP)
Target	Human Fatty Acid Binding Protein (HFABP)
Expression platform	Synthetic
Bioactivity validation	Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Human Fatty Acid Binding Protein (HFABP)

Cat No.	GMP-SMT-HFABP-Ag02
Product Name	OVA-Human Fatty Acid Binding Protein (HFABP)
Target	Human Fatty Acid Binding Protein (HFABP)
Expression platform	Synthetic
Bioactivity validation	Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation/td>
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)

Cat No.	GMP-SMT-HFABP-Ab01
Product Name	Anti-human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)
Target	Human Fatty Acid Binding Protein (HFABP)
Expression platform	hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Human Fatty Acid Binding Protein (HFABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Fatty Acid Binding Protein (HFABP) antibodies in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
Purity	High (TBD)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Fatty Acid Binding Protein (HFABP) human monoclonal antibody (mAb)

Cat No.	GMP-SMT-HFABP-Ab02
Product Name	Anti-human Fatty Acid Binding Protein (HFABP) human monoclonal antibody (mAb)
Target	Human Fatty Acid Binding Protein (HFABP)
Expression platform	hybridoma
Isotypes	Human IgG1
Bioactivity validation	Human Fatty Acid Binding Protein (HFABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Fatty Acid Binding Protein (HFABP) antibodies in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
Purity	Purity: ≥95% （SDS-PAGE）
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Supplied as a 0.2 μM filtered solution of PBS, PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

The fatty acid binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. These proteins are thought to facilitate the transfer of fatty acids between extracellular and intracellular membranes. FABP4 has been associated with several components of metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation, and thus, it has been proposed as a cardiometabolic predictor for cardiovascular disease.

About GDU